Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
100 subjects who have a family history of pancreatic cancer (PC), or known genetic syndromes associated with increased risk of pancreatic cancer, will be followed for five years. This data will be used to determine the pancreatic cancer and precancerous lesion detection rate in High Risk Individuals (HRIs). Subjects may agree to annual imaging and annual biomarkers or to biomarkers only.
Pancreatic Neoplasms|Peutz-Jegher's Syndrome|BRCA1 Gene Mutation|BRCA2 Gene Mutation|Ataxia Telangiectasia|Familial Atypical Mole-Malignant Melanoma Syndrome|Colorectal Neoplasms, Hereditary Nonpolyposis|Hereditary Pancreatitis
OTHER: Pancreatic Cancer Screening Pathway 1|OTHER: Pancreatic Cancer Screening Pathway 2
Detection rate of PC and precancerous lesion, 5 years
100 subjects who have a family history of pancreatic cancer (PC), or known genetic syndromes associated with increased risk of pancreatic cancer, will be followed for five years. This data will be used to determine the pancreatic cancer and precancerous lesion detection rate in High Risk Individuals (HRIs). Subjects may agree to annual imaging and annual biomarkers or to biomarkers only.